NCT02886468 (DEEP) is a NA clinical trial of skin ultrasound in Anaphylactic Shock, sponsored by Centre Hospitalier Régional Metz-Thionville.

Who is sponsoring NCT02886468?

NCT02886468 is sponsored by Centre Hospitalier Régional Metz-Thionville.

What drugs are being tested in NCT02886468?

Interventions in NCT02886468: skin ultrasound.

What condition does NCT02886468 study?

NCT02886468 studies Anaphylactic Shock.

Is NCT02886468 still recruiting?

NCT02886468 is currently completed. Last updated 26 August 2021.

Last reviewed 2021-08-26 · How we verify

NCT02886468: DEEP

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

DEpth of EPinephrine Delivery With Auto-injectors Devices

Completed NA Last updated 26 August 2021

What this trial tests

NA trial testing skin ultrasound in Anaphylactic Shock in 107 participants. Completed in 16 August 2021.

Timeline

26 August 2016

Primary endpoint
4 May 2021

16 August 2021

Quick facts

Lead sponsor	Centre Hospitalier Régional Metz-Thionville
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	other
Enrollment	107
Start date	26 August 2016
Primary completion	4 May 2021
Estimated completion	16 August 2021
Sites	1 location across France

Drugs / interventions tested

skin ultrasound

Conditions studied

Anaphylactic Shock — all drugs for Anaphylactic Shock →

Sponsor

Centre Hospitalier Régional Metz-Thionville

Who can join

18 and older, any sex, with Anaphylactic Shock. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Anaphylaxis is a serious allergic reaction that is rapid in onset and may cause death. Although there are several causes of fatal anaphylaxis, food allergy is one of the most common. Epinephrine is recommended as the initial treatment of choice for anaphylaxis. A delay in epinephrine administration may contribute to an increased risk of death. Therefore, the World Allergy Organization recommends that, for the treatment of anaphylaxis, epinephrine solution be administered intramuscularly in the mid-anterolateral thigh. In France 3 auto-injector pens are available: Anapen®, Epipen® and Jext®. For weight\> 30 kg, the devices have a needle size respectively of 7.49 mm, 15.02 mm and 15.36 mm. For the weights between 15 and 30 kg needle size is 7.49 mm to 12.7 mm and Anapen® for Epipen® and Jext®. Several studies suggest that the needle length needle is sometim

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Frequencies and predictors of subcutaneous and intraosseous injection with 4 epinephrine autoinjector devices.
Lefevre S, Goetz C, Hennequin L, Zevering Y, et al · · 2024 · cited 2× · PMID 38740133 · DOI 10.1016/j.anai.2024.05.002

Verify or expand the search:

Other recruiting trials for Anaphylactic Shock

Currently open trials in the same condition.

NCT06192914 — EPAP, Interviewstudy · recruiting

Other Centre Hospitalier Régional Metz-Thionville trials

Trials by the same sponsor.

NCT07435389 — VENTILATION DURING SPACEFLIGHT (PHASE 2) · NA · not yet recruiting
NCT07405996 — Referral of Patients With Biological Abnormalities to an Emergency Department · not yet recruiting
NCT07406022 — Optical Characterization and Multi-modality, Multi-scale Modeling of Human Skin Applied to Cancer Diagnosis. · not yet recruiting
NCT07515404 — A New Multimodal and Semi-specific Therapeutic Plasmapheresis Concept, a Case Series Study · completed
NCT07390604 — Case Series : Management of Elevated Lipoprotein(a) Using Double-Filtration Plasmapheresis (DFPP) in Hemodialysis Patien · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT02886468 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Centre Hospitalier Régional Metz-Thionville
Last refreshed: 26 August 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02886468.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing